Bimekizumab versus Ustekinumab Efficacy Across Subgroups of Patients with Moderate to Severe Plaque Psoriasis: Results from the Multicenter, Randomized, Double-Blinded Phase 3 BE VIVID Trial. (2021). SKIN The Journal of Cutaneous Medicine, 5(1), s16. https://doi.org/10.25251/skin.5.supp.16